Diethylpropion: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Diethylpropion. Educational only — not medical advice.

Labeled uses

Diethylpropion hydrochloride tablets USP, 25 mg are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of BMI based on various heights and weights. BMI is calculated by taking the patient's weight, in kilograms (kg), divided by the patient's height, in meters (m), squared. Metric conversions are as follows: pounds divided by 2.2 = kg; inches × 0.0254 = meters. Body Mass Index (BMI), kg/m 2 Weight (pounds) | Height (feet, inches) |   |  5'0" |  5'3" |  5'6" |  5'9" |  6'0" |  6'3" |  140 |  27 |  25 |  23 |  21 |  19 |  18 |  150 |  29 |  27 |  24 |  22 |  20 |  19 |  160 |  31 |  28 |  26 |  24 |  22 |  20 |  170 |  33 |  30 |  28 |  25 |  23 |  21 |  180 |  35 |  32 |  29 |  27 |  25 |  23 |  190 |  37 |  34 |  31 |  28 |  26 |  24 |  200 |  39 |  36 |  32 |  30 |  27 |  25 |  210 |  41 |  37 |  34 |  31 |  29 |  26 |  220 |  43 |  39 |  36 |  33 |  30 |  28 |  230 |  45 |  41 |  37 |  34 |  31 |  29 |…

Source: FDA labeling via NIH DailyMed (set 5777eed8…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.